Literature DB >> 4015217

Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator.

J W Kelly, R W Sagebiel, S Clyman, M S Blois.   

Abstract

A small proportion of "thin" malignant melanomas will metastasize and cause death. To assess the role of discordance between the major indicators of tumor depth (thickness and level) as a possible explanation for this phenomenon, prognosis by level has been examined in 255 cases, with tumors ranging in thickness from 0.6 to 1.1 mm. This is the range of thickness at which levels II, III, and IV overlap. The 5-year survival rate of patients with level IV tumors in this thickness range (59.35%) was poor (p less than 0.0001), relative to that of patients with level II (96.8%) and III (94.49%) lesions in the same range of tumor thickness. The distributions of other major prognostic indicators, among the groups of patients with tumors at each level, were examined to assess the possible contribution of factors other than level to the differences in survival between the three groups. These differences in survival could not be attributed to differing distributions of tumor thickness, tumor location, or patient sex. Of six prognostic variables, examined by Cox multivariate regression analysis, for tumors of thickness 0.6 to 1.1 mm, only level was found to have independent prognostic significance (p = 0.0025). The thin level IV melanoma appears to be an important exception to the rule that this melanomas are associated with an excellent prognosis. In this, as well as in other studies, after accounting for the effect on prognosis of tumor thickness, level has been shown to be a prognostic indicator with independent significance. The continued use of level as a prognostic indicator, in addition to thickness, is recommended.

Entities:  

Mesh:

Year:  1985        PMID: 4015217      PMCID: PMC1250844          DOI: 10.1097/00000658-198507000-00016

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  23 in total

1.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

2.  Low- and high-risk malignant melanoma--I. Evaluation of clinical and histological prognosticators in 585 cases.

Authors:  C Schmoeckel; A Bockelbrink; H Bockelbrink; J Koutsis; O Braun-Falco
Journal:  Eur J Cancer Clin Oncol       Date:  1983-02

Review 3.  Changing concepts in melanoma management.

Authors:  F Rampen
Journal:  Br J Dermatol       Date:  1981-03       Impact factor: 9.302

4.  The skin.

Authors:  R F Rushmer; K J Buettner; J M Short; G F Odland
Journal:  Science       Date:  1966-10-21       Impact factor: 47.728

Review 5.  The developmental biology of primary human malignant melanomas.

Authors:  W H Clark; A M Ainsworth; E A Bernardino; C H Yang; C M Mihm; R J Reed
Journal:  Semin Oncol       Date:  1975-06       Impact factor: 4.929

6.  Judging prognosis in malignant melanoma of the skin. A problem of inference over small data sets.

Authors:  M S Blois; R W Sagebiel; M S Tuttle; T M Caldwell; H W Taylor
Journal:  Ann Surg       Date:  1983-08       Impact factor: 12.969

7.  Metastasis and death in patients with thin melanomas (less than 0.76 mm).

Authors:  J E Woods; E H Soule; E T Creagan
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

8.  Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients.

Authors:  G W Milton; H M Shaw; W H McCarthy; L Pearson; C M Balch; S J Soong
Journal:  Br J Surg       Date:  1982-02       Impact factor: 6.939

9.  Malignant melanoma of the skin. I. The association of tumor depth and type, and patient sex, age, and site with survival.

Authors:  M S Blois; R W Sagebiel; R M Abarbanel; T M Caldwell; M S Tuttle
Journal:  Cancer       Date:  1983-10-01       Impact factor: 6.860

10.  Regression in malignant melanoma.

Authors:  H Trau; A W Kopf; D S Rigel; J Levine; G Rogers; M Levenstein; R S Bart; M M Mintzis; R J Friedman
Journal:  J Am Acad Dermatol       Date:  1983-03       Impact factor: 11.527

View more
  3 in total

1.  Lethal "thin" malignant melanoma. Identifying patients at risk.

Authors:  C L Slingluff; R T Vollmer; D S Reintgen; H F Seigler
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

2.  Morphometric, DNA and PCNA in thin malignant melanomas.

Authors:  V Björnhagen; E Månsson-Brahme; J Lindholm; A Mattsson; G Auer
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

3.  Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).

Authors:  Richard A Scolyer; Meagan J Judge; Alan Evans; David P Frishberg; Victor G Prieto; John F Thompson; Martin J Trotter; Maureen Y Walsh; Noreen M G Walsh; David W Ellis
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.